# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031423
Filing Date
2022-11-10
Accepted
2022-11-10 17:01:00
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1297668
2 |  | ex10-2.htm | EX-10.2 | 13203
3 |  | ex10-3.htm | EX-10.3 | 12069
4 |  | ex31-1.htm | EX-31.1 | 11634
5 |  | ex31-2.htm | EX-31.2 | 18191
6 |  | ex32-1.htm | EX-32.1 | 4896
7 |  | ex32-2.htm | EX-32.2 | 4853
| Complete submission text file | 0001493152-22-031423.txt |  | 7114323

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | mymd-20220930.xsd | EX-101.SCH | 51031
9 | XBRL CALCULATION FILE | mymd-20220930_cal.xml | EX-101.CAL | 52589
10 | XBRL DEFINITION FILE | mymd-20220930_def.xml | EX-101.DEF | 263340
11 | XBRL LABEL FILE | mymd-20220930_lab.xml | EX-101.LAB | 466608
12 | XBRL PRESENTATION FILE | mymd-20220930_pre.xml | EX-101.PRE | 371807
63 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1162977

Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 221378296
SIC: 2835 In Vitro & In Vivo Diagnostic Substances